Company Profile
Dx & Vx provides the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea. The company offers healthcare products, including Ofmom Carefree, oat fermented food, and biocleaners.
Its portfolio also includes diagnostic products, comprising CLIDEX, precision diagnostics, and in vitro diagnostic kit, health check services, CDx development services, medical data, and funeral home operation services.
It provides bacterial vaccine for respiratory disease. Its portfolio also includes macular degeneration drug, atopy dermatitis drugs, xeropthalmia drugs, anticancer vaccine, and new antibody drugs. Its pipeline includes Vx product, oral pediatric Covid19/influenza vaccine.
Its portfolio also includes new anti-cancer antibody drug, an antibody drug utilizing advanced mRNA vaccine development technique, Vx Microbiome R&D pipeline, a bacterial vaccine against respiratory diseases, new drugs targeting obesity and diagnosis etc, and Oxford Vacmedix Vaccine, an anti-cancer vaccineutilizing ROP technology.
It has a research collaboration with bereum, Bioapp, CORESTEMCHEMON, Genscript PROBIO, JOINTOWN PHARMACEUTICAL GROUP,etc. Founded in 2001 and based in Seoul, South Korea, the company was formerly known as Cancer Rop Co., Ltd. before rebranding in January 2022.